Vaccine Technologies Market Report 2026
Download Free Sample Buy Now
Vaccine Technologies Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Vaccine Technologies Market Report 2026

Global Outlook – By Type (Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid), By Route Of Administration (Parenteral, Oral, Nasal), By Disease Indication (Infectious Diseases, Non-Infectious Diseases), By Age Group (Pediatric, Adults), By Distribution Channel (Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Vaccine Technologies Market Overview

• Vaccine Technologies market size has reached to $61.38 billion in 2025

• Expected to grow to $99.04 billion in 2030 at a compound annual growth rate (CAGR) of 10%

• Growth Driver: Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Global Travel And Pathogen Spread

• Market Trend: Quadrivalent Vaccines Provide Broader Protection Against Flu Strains

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vaccine Technologies Market?

Vaccine technologies refer to the scientific methods and tools used to develop, produce, and deliver vaccines that stimulate the immune system to recognize and fight pathogens such as viruses, bacteria, or other harmful microorganisms. The main purpose of vaccine technologies is to safely induce immunity, preventing illness and controlling the spread of pathogens.

The main types of vaccine technologies are recombinant or conjugate or subunit, inactivated, live attenuated, and toxoid. Recombinant or conjugate or subunit vaccines use specific pieces of the virus or bacteria, such as proteins or sugars, instead of the whole germ to safely stimulate the immune system. They are administered through various routes, including parenteral, oral, and nasal delivery, and are intended for both infectious and non-infectious disease indications. Vaccine technologies are suitable for all age groups, including pediatric and adult populations, and are distributed through multiple channels such as hospitals and retail pharmacies, government suppliers, and others.

Vaccine Technologies Market Global Report 2026 Market Report bar graph

What Is The Vaccine Technologies Market Size and Share 2026?

The vaccine technologies market size has grown rapidly in recent years. It will grow from $61.38 billion in 2025 to $67.71 billion in 2026 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to expansion of national immunization initiatives, increased public health funding, advancements in vaccine production technologies, growth in infectious disease surveillance, establishment of global vaccine supply chains.

What Is The Vaccine Technologies Market Growth Forecast?

The vaccine technologies market size is expected to see strong growth in the next few years. It will grow to $99.04 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing investments in next-generation vaccine platforms, rising demand for pandemic preparedness solutions, expansion of adult vaccination programs, growing focus on non-infectious disease vaccines, increasing adoption of digital vaccine tracking systems. Major trends in the forecast period include increasing development of mrna and recombinant vaccines, rising focus on rapid vaccine manufacturing platforms, growing adoption of novel delivery technologies, expansion of global immunization programs, enhanced emphasis on cold chain optimization.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Vaccine Technologies Market Segmentation

1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

2) By Route Of Administration: Parenteral, Oral, Nasal

3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases

4) By Age Group: Pediatric, Adults

5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

Subsegments:

1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

What Is The Driver Of The Vaccine Technologies Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the vaccine technologies market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one person to another. The rising prevalence of infectious diseases is due to increased travel, which facilitates the rapid spread of pathogens across borders. Vaccine technologies aid infectious disease treatment by stimulating targeted immune responses, helping prevent and control infections. They support public health efforts by reducing disease spread and severity, improving overall healthcare outcomes. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government agency, tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England rose to 4,850 in 2023, an increase of 10.7% from 4,380 cases in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the vaccine technologies industry.

Key Players In The Global Vaccine Technologies Market

Major companies operating in the vaccine technologies market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited

Global Vaccine Technologies Market Trends and Insights

Major companies operating in the vaccine technologies market are focusing on developing innovative solutions, such as quadrivalent influenza vaccines, to provide broader immunization coverage and minimize the risk of strain mismatch. Quadrivalent influenza vaccines are vaccines formulated to protect against four influenza virus strains, two influenza A and two influenza B viruses, offering broader protection than trivalent vaccines. For instance, in February 2025, Zydus Lifesciences, an India-based pharmaceutical company, launched VaxiFlu-4, a quadrivalent influenza vaccine. The vaccine offers seasonal protection against four influenza strains, including both influenza A and B types, and is administered as a single-dose intramuscular injection and is suitable for use in both adults and children. It helps reduce the burden of seasonal influenza by offering broader strain coverage compared to traditional trivalent vaccines.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Vaccine Technologies Market?

In December 2023, AstraZeneca plc, a UK-based biopharmaceutical company, acquired Icosavax Inc. for $1.1 billion. With this acquisition, AstraZeneca aims to enhance its respiratory vaccine portfolio by integrating Icosavax's innovative protein virus-like particle (VLP) platform, which includes the phase III-ready combination vaccine candidate IVX-A12 targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax is a US-based biotechnology company specializing in vaccine technologies, particularly in developing virus-like particle (VLP)-based vaccines for respiratory diseases.

Regional Outlook

North America was the largest region in the vaccine technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Vaccine Technologies Market?

The vaccine technologies market consists of revenues earned by entities by providing services such as vaccine research and development, formulation and testing, clinical trials management, regulatory support, manufacturing process optimization, and distribution logistics for vaccines. The market value includes the value of related goods sold by the service provider or included within the service offering. The vaccine technologies market also includes sales of mRNA vaccines, viral vector vaccines, protein subunit vaccines, and related raw materials and reagents used in vaccine development and production. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Vaccine Technologies Market Report 2026?

The vaccine technologies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vaccine technologies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Vaccine Technologies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $67.71 billion
Revenue Forecast In 2035 $99.04 billion
Growth Rate CAGR of 10.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Route Of Administration, Disease Indication, Age Group, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Vaccine Technologies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Vaccine Technologies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Vaccine Technologies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Vaccine Technologies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Industry 4.0 & Intelligent Manufacturing

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Increasing Development Of Mrna And Recombinant Vaccines

4.2.2 Rising Focus On Rapid Vaccine Manufacturing Platforms

4.2.3 Growing Adoption Of Novel Delivery Technologies

4.2.4 Expansion Of Global Immunization Programs

4.2.5 Enhanced Emphasis On Cold Chain Optimization

5. Vaccine Technologies Market Analysis Of End Use Industries

5.1 Vaccine Manufacturers

5.2 Pharmaceutical Companies

5.3 Government Health Agencies

5.4 Hospitals And Clinics

5.5 Research And Development Institutes

6. Vaccine Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Vaccine Technologies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Vaccine Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Vaccine Technologies Market Size, Comparisons And Growth Rate Analysis

7.3. Global Vaccine Technologies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Vaccine Technologies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Vaccine Technologies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Vaccine Technologies Market Segmentation

9.1. Global Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid

9.2. Global Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parenteral, Oral, Nasal

9.3. Global Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infectious Diseases, Non-Infectious Diseases

9.4. Global Vaccine Technologies Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric, Adults

9.5. Global Vaccine Technologies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels

9.6. Global Vaccine Technologies Market, Sub-Segmentation Of Recombinant Or Conjugate Or Subunit, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines

9.7. Global Vaccine Technologies Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines

9.8. Global Vaccine Technologies Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines

9.9. Global Vaccine Technologies Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines

10. Vaccine Technologies Market Regional And Country Analysis

10.1. Global Vaccine Technologies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Vaccine Technologies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Vaccine Technologies Market

11.1. Asia-Pacific Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Vaccine Technologies Market

12.1. China Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Vaccine Technologies Market

13.1. India Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Vaccine Technologies Market

14.1. Japan Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Vaccine Technologies Market

15.1. Australia Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Vaccine Technologies Market

16.1. Indonesia Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Vaccine Technologies Market

17.1. South Korea Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Vaccine Technologies Market

18.1. Taiwan Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Vaccine Technologies Market

19.1. South East Asia Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Vaccine Technologies Market

20.1. Western Europe Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Vaccine Technologies Market

21.1. UK Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Vaccine Technologies Market

22.1. Germany Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Vaccine Technologies Market

23.1. France Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Vaccine Technologies Market

24.1. Italy Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Vaccine Technologies Market

25.1. Spain Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Vaccine Technologies Market

26.1. Eastern Europe Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Vaccine Technologies Market

27.1. Russia Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Vaccine Technologies Market

28.1. North America Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Vaccine Technologies Market

29.1. USA Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Vaccine Technologies Market

30.1. Canada Vaccine Technologies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Vaccine Technologies Market

31.1. South America Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Vaccine Technologies Market

32.1. Brazil Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Vaccine Technologies Market

33.1. Middle East Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Vaccine Technologies Market

34.1. Africa Vaccine Technologies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Vaccine Technologies Market, Segmentation By Type, Segmentation By Route Of Administration, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Vaccine Technologies Market Regulatory and Investment Landscape

36. Vaccine Technologies Market Competitive Landscape And Company Profiles

36.1. Vaccine Technologies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Vaccine Technologies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Vaccine Technologies Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis

37. Vaccine Technologies Market Other Major And Innovative Companies

GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE

38. Global Vaccine Technologies Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Vaccine Technologies Market

40. Vaccine Technologies Market High Potential Countries, Segments and Strategies

40.1 Vaccine Technologies Market In 2030 - Countries Offering Most New Opportunities

40.2 Vaccine Technologies Market In 2030 - Segments Offering Most New Opportunities

40.3 Vaccine Technologies Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Vaccine Technologies Market, Overview Of Key Products - Product Examples
  • Table 2: Global Vaccine Technologies Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Vaccine Technologies Market, Supply Chain Analysis
  • Table 4: Global Vaccine Technologies Market, Major Raw Material Providers
  • Table 5: Global Vaccine Technologies Market, Major Resource Providers
  • Table 6: Global Vaccine Technologies Market, Major Manufacturers (Suppliers)
  • Table 7: Global Vaccine Technologies Market, Major Distributors And Channel Partners
  • Table 8: Global Vaccine Technologies Market, Key Technologies & Future Trends
  • Table 9: Global Vaccine Technologies Market, Major Trends
  • Table 10: Global Vaccine Technologies Market, Major End Users
  • Table 11: Global Vaccine Technologies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Vaccine Technologies Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Vaccine Technologies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Vaccine Technologies Market - TAM, US$ Billion, 2025
  • Table 15: Global Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Vaccine Technologies Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Vaccine Technologies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Vaccine Technologies Market, Sub-Segmentation Of Recombinant Or Conjugate Or Subunit, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Vaccine Technologies Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Vaccine Technologies Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Vaccine Technologies Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Vaccine Technologies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Vaccine Technologies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Vaccine Technologies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Vaccine Technologies Market - Company Scoring Matrix
  • Table 100: Pfizer Inc Financial Performance
  • Table 101: Johnson And Johnson Financial Performance
  • Table 102: Merck And Co Inc Financial Performance
  • Table 103: Sanofi SA Financial Performance
  • Table 104: AstraZeneca Plc Financial Performance
  • Table 105: Global Vaccine Technologies Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Vaccine Technologies Market, Competitive Dashboard
  • Table 107: Global Vaccine Technologies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 109: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 110: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

List Of Figures

    Figure 1: Global Vaccine Technologies Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Vaccine Technologies Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Vaccine Technologies Market, Supply Chain Analysis
  • Figure 4: Global Vaccine Technologies Market, Major Raw Material Providers
  • Figure 5: Global Vaccine Technologies Market, Major Resource Providers
  • Figure 6: Global Vaccine Technologies Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Vaccine Technologies Market, Major Distributors And Channel Partners
  • Figure 8: Global Vaccine Technologies Market, Key Technologies & Future Trends
  • Figure 9: Global Vaccine Technologies Market, Major Trends
  • Figure 10: Global Vaccine Technologies Market, Major End Users
  • Figure 11: Global Vaccine Technologies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Vaccine Technologies Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Vaccine Technologies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Vaccine Technologies Market - TAM, US$ Billion, 2025
  • Figure 15: Global Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Vaccine Technologies Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Vaccine Technologies Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Vaccine Technologies Market, Sub-Segmentation Of Recombinant Or Conjugate Or Subunit, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Vaccine Technologies Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Vaccine Technologies Market, Sub-Segmentation Of Live Attenuated, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Vaccine Technologies Market, Sub-Segmentation Of Toxoid, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Vaccine Technologies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Vaccine Technologies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Vaccine Technologies Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Vaccine Technologies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Vaccine Technologies Market, Segmentation By Disease Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Vaccine Technologies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Vaccine Technologies Market - Company Scoring Matrix
  • Figure 100: Pfizer Inc Financial Performance
  • Figure 101: Johnson And Johnson Financial Performance
  • Figure 102: Merck And Co Inc Financial Performance
  • Figure 103: Sanofi SA Financial Performance
  • Figure 104: AstraZeneca Plc Financial Performance
  • Figure 105: Global Vaccine Technologies Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Vaccine Technologies Market, Competitive Dashboard
  • Figure 107: Global Vaccine Technologies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 109: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 110: Global, Vaccine Technologies Market Size Gain ($ Billion), Segmentation By Disease Indication, 2025 – 2030

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Healthcare Information Technology (IT) Outsourcing Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Meningococcal Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Childre...

Swine Vaccines Market Report 2026 - Global Outlook – By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines), By Disease (Viral Infections...

Typhoid Vi Polysaccharide Vaccine Market Report 2026 - Global Outlook – By Type (Child, Adult ), By Route Of Administration (Oral, Parenteral ), By Application (Government Institution, Private Sector, Other Applications ...

Dog Vaccines Market Report 2026 - Global Outlook – By Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Route Of Administ...

Foot And Mouth Disease Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines), By Animal Type (Cattle, ...

Chickenpox Vaccine Market Report 2026 - Global Outlook – By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immuni...

Poultry Vaccines Market Report 2026 - Global Outlook – By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease Type (Avain Influen...

Adult Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Con...

Frequently Asked Questions

The Vaccine Technologies Market Report 2026 market was valued at $61.38 billion in 2025, increased to $67.71 billion in 2026, and is projected to reach $99.04 billion by 2030. request a sample here

The expected CAGR for the Vaccine Technologies Market Report 2026 market during the forecast period 2025–2030 is 10.0%. request a sample here

Major growth driver of the market includes: Increasing Prevalence Of Infectious Diseases Fueling The Growth Of The Market Due To Rising Global Travel And Pathogen Spread in the Vaccine Technologies Market Report 2026 market. For further insights on this market, request a sample here

The vaccine technologies market covered in this report is segmented –
1) By Type: Recombinant Or Conjugate Or Subunit, Inactivated, Live Attenuated, Toxoid
2) By Route Of Administration: Parenteral, Oral, Nasal
3) By Disease Indication: Infectious Diseases, Non-Infectious Diseases
4) By Age Group: Pediatric, Adults
5) By Distribution Channel: Hospital And Retail Pharmacies, Government Suppliers, Other Distribution Channels Subsegments:
1) By Recombinant Or Conjugate Or Subunit: Protein Subunit Vaccines, Virus-Like Particle (VLP) Vaccines, Glycoconjugate Vaccines, Recombinant Vector Vaccines
2) By Inactivated: Whole-Virus Inactivated Vaccines, Split-Virus Inactivated Vaccines, Purified Inactivated Vaccines
3) By Live Attenuated: Viral Live Attenuated Vaccines, Bacterial Live Attenuated Vaccines
4) By Toxoid: Diphtheria Toxoid Vaccines, Tetanus Toxoid Vaccines request a sample here

Major trend in this market includes: Quadrivalent Vaccines Provide Broader Protection Against Flu Strains For further insights on this market, request a sample here.

Major companies operating in the Vaccine Technologies Market Report 2026 market are Major companies operating in the vaccine technologies market are Pfizer Inc, Johnson And Johnson, Merck And Co Inc, Sanofi SA, AstraZeneca Plc, GSK Plc, Moderna Inc, CSL Limited, Bharat Biotech International Limited, Bavarian Nordic AS, Takeda Pharmaceutical Company Limited, Sinovac Biotech Ltd, Emergent BioSolutions Inc, Valneva SE, Novavax Inc, Dynavax Technologies Corporation, CureVac NV, Inovio Pharmaceuticals Inc, Serum Institute Of India Pvt Ltd, BioNTech SE, Panacea Biotec Ltd, Biological E Limited request a sample here.

North America was the largest region in the vaccine technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vaccine technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us